Endo executes master settlement agreement to resolve testosterone lawsuits

Two Endo International subsidiaries, Endo Pharmaceuticals and Auxilium Pharmaceuticals, have executed a definitive master settlement agreement to resolve all known testosterone replacement therapy product liability claims against the company. The agreement does not involve any admission of wrongdoing or liability by Endo, which is based in Dublin, Ireland, and has its U.S. headquarters in Malvern, Pa. Endo and its subsidiaries are defendants in more than 1,200 lawsuits filed by users of testosterone…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news